marketcaparena
Search

    PIII

    P3 Health Partners Inc.

    Company overview

    Market capitalization
    —
    Employees
    320
    Latest publication
    2026-09-29
    About P3 Health Partners Inc.

    P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue386,390,000USD384,814,000USD345,253,000USD355,788,000USD373,225,000USD370,686,000USD362,124,000USD379,157,000USD
    Cost Of Revenue357,098,000USD447,053,000USD369,789,000USD—379,005,000USD768,767,000USD21,838,000USD365,171,000USD
    Gross Profit386,390,000USD384,814,000USD-24,536,000USD355,788,000USD-5,780,000USD370,686,000USD362,124,000USD13,986,000USD
    Selling General Administrative25,543,000USD35,878,000USD22,139,000USD23,295,000USD24,999,000USD31,366,000USD27,219,000USD26,610,000USD
    Selling And Marketing Expenses227,000USD335,000USD—151,000USD181,000USD461,000USD134,000USD414,000USD
    Unclassified Operating Expenses352,383,000USD502,467,000USD-2,452,000USD366,466,000USD7,128,000USD477,362,000USD441,761,000USD18,296,000USD
    Total Operating Expenses378,153,000USD538,680,000USD19,687,000USD389,912,000USD32,308,000USD509,189,000USD469,114,000USD45,320,000USD
    Operating Income8,237,000USD-153,866,000USD-44,223,000USD-34,124,000USD-38,088,000USD-138,503,000USD-106,990,000USD-31,334,000USD
    Interest Expense16,766,000USD15,637,000USD20,527,000USD10,145,000USD8,725,000USD6,834,000USD5,647,000USD5,436,000USD
    Net Interest Income-16,766,000USD-15,637,000USD-20,527,000USD-10,145,000USD-8,725,000USD-6,834,000USD-5,647,000USD-5,436,000USD
    Income Before Tax-7,957,000USD-166,754,000USD-69,450,000USD-41,684,000USD-43,173,000USD-124,196,000USD-106,455,000USD-27,806,000USD
    Income Tax Expense-10,997,000USD-1,040,000USD11,000USD1,981,000USD1,073,000USD4,952,000USD-3,605,000USD968,000USD
    Tax Provision-10,997,000USD-1,040,000USD11,000USD1,981,000USD1,073,000USD4,952,000USD-3,605,000USD968,000USD
    Net Income1,223,000USD-75,519,000USD-31,587,000USD-20,362,000USD-20,480,000USD-58,617,000USD-46,512,000USD-12,020,000USD
    Net Income From Continuing Ops3,040,000USD-165,714,000USD-69,461,000USD-43,665,000USD-44,246,000USD-129,148,000USD-102,850,000USD-28,774,000USD
    Ebit8,809,000USD-151,117,000USD-48,923,000USD-31,539,000USD-34,448,000USD-117,362,000USD-100,808,000USD-22,370,000USD
    Ebitda29,883,000USD-130,122,000USD-27,890,000USD-10,456,000USD-13,396,000USD-96,209,000USD-79,135,000USD-677,000USD
    Depreciation And Amortization21,074,000USD20,995,000USD21,033,000USD21,083,000USD21,052,000USD21,153,000USD21,673,000USD21,693,000USD
    Reconciled Depreciation21,074,000USD20,995,000USD21,033,000USD21,083,000USD21,052,000USD21,153,000USD21,673,000USD21,693,000USD
    Total Other Income Expense Net-16,194,000USD-12,888,000USD-25,227,000USD-7,560,000USD-5,085,000USD6,249,000USD535,000USD3,528,000USD
    Minority Interest-1,817,000USD90,195,000USD37,874,000USD23,303,000USD23,766,000USD70,531,000USD56,338,000USD16,754,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue1,459,080,000USD1,500,455,000USD1,266,375,000USD1,049,471,000USD—491,063,525USD145,482,112USD87,696,694USD
    Cost Of Revenue1,603,403,000USD1,559,372,000USD1,234,740,000USD668,066,009USD—485,297,595USD141,029,737USD—
    Gross Profit-144,323,000USD1,500,455,000USD1,266,375,000USD1,049,471,000USD—491,063,525USD145,482,112USD87,696,694USD
    Selling General Administrative106,311,000USD112,596,000USD122,362,000USD157,284,000USD—53,390,338USD36,423,532USD28,541,520USD
    Selling And Marketing Expenses918,000USD1,331,000USD3,233,000USD5,096,000USD—1,502,634USD801,685USD1,870,004USD
    Unclassified Operating Expenses18,749,000USD1,707,186,000USD1,308,710,000USD2,448,004,000USD—464,758,231USD147,792,566USD106,999,685USD
    Total Operating Expenses125,978,000USD1,821,113,000USD1,434,305,000USD2,610,384,000USD—519,651,203USD185,017,783USD137,411,209USD
    Operating Income-270,301,000USD-320,658,000USD-167,930,000USD-1,560,913,000USD—-28,587,678USD-39,535,671USD-49,714,513USD
    Interest Expense55,034,000USD22,173,000USD15,985,000USD11,404,000USD—2,533,180USD2,533,842USD44,235USD
    Net Interest Income-55,034,000USD-22,173,000USD-14,925,000USD-11,404,000USD—-9,970,260USD-3,479,139USD44,235USD
    Income Before Tax-321,061,000USD-305,991,000USD-183,731,000USD-1,559,695,000USD—-31,411,542USD-41,971,558USD-49,774,014USD
    Income Tax Expense2,025,000USD4,387,000USD2,695,000USD1,862,000USD—-3,999,774USD2,631,797USD-6,016,954USD
    Tax Provision2,025,000USD4,387,000USD2,790,000USD1,862,000USD—0USD0USD—
    Net Income-147,948,000USD-135,849,000USD-57,773,000USD-270,127,000USD—-31,411,542USD-41,971,558USD-43,801,295USD
    Net Income From Continuing Ops-323,086,000USD-310,378,000USD-649,651,000USD-1,561,557,000USD—-45,381,576USD-42,916,855USD-49,774,014USD
    Ebit-270,301,000USD-283,818,000USD-167,746,000USD-1,548,291,000USD-187,946,000USD-28,878,362USD-39,437,716USD-49,714,515USD
    Ebitda-186,138,000USD-197,760,000USD-81,071,000USD-1,461,002,000USD—-28,083,190USD-39,038,539USD-49,372,319USD
    Depreciation And Amortization84,163,000USD86,058,000USD86,675,000USD87,289,000USD—795,172USD399,177USD342,196USD
    Reconciled Depreciation84,163,000USD86,058,000USD87,043,000USD87,289,000USD—795,172USD399,177USD342,196USD
    Total Other Income Expense Net-50,760,000USD6,609,000USD-15,801,000USD1,218,000USD—-2,823,864USD-2,435,887USD-59,501USD
    Minority Interest175,138,000USD174,529,000USD523,313,000USD1,291,430,000USD—4,307,071USD7,907,592USD5,972,718USD
    Net Income Applicable To Common Shares————-10,081,000USD-41,074,505USD-35,009,263USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets674,157,000USD656,641,000USD683,564,000USD731,585,000USD783,870,000USD783,420,000USD833,333,000USD892,759,000USD
    Intangible Assets472,989,000USD492,423,000USD512,912,000USD533,400,000USD553,889,000USD574,350,000USD594,865,000USD624,673,000USD
    Other Current Assets21,819,000USD15,613,000USD15,893,000USD16,915,000USD16,594,000USD20,111,000USD26,291,000USD13,594,000USD
    Total Liab807,324,000USD796,876,000USD664,636,000USD644,407,000USD662,791,000USD633,891,000USD569,422,000USD527,932,000USD
    Total Stockholder Equity-143,548,000USD-155,232,000USD-18,686,000USD44,459,000USD63,250,000USD75,936,000USD120,514,000USD166,840,000USD
    Other Current Liab462,377,000USD130,886,000USD375,413,000USD368,277,000USD373,020,000USD367,408,000USD350,473,000USD320,583,000USD
    Capital Stock0USD0USD0USD0USD0USD36,000USD36,000USD36,000USD
    Retained Earnings-649,918,000USD-651,141,000USD-575,622,000USD-544,035,000USD-523,673,000USD-503,193,000USD-444,576,000USD-398,064,000USD
    Cash25,497,000USD25,012,000USD37,714,000USD38,581,000USD40,082,000USD38,816,000USD62,962,000USD73,086,000USD
    Cash And Short Term Investments25,497,000USD25,012,000USD37,714,000USD38,581,000USD40,082,000USD38,816,000USD62,962,000USD73,086,000USD
    Total Current Assets172,210,000USD133,083,000USD135,631,000USD156,531,000USD191,435,000USD184,140,000USD215,073,000USD242,104,000USD
    Total Current Liabilities525,485,000USD545,257,000USD423,954,000USD504,998,000USD507,034,000USD496,415,000USD405,318,000USD352,254,000USD
    Net Debt36,769,000USD31,499,000USD12,951,000USD154,138,000USD142,816,000USD127,347,000USD81,632,000USD73,061,000USD
    Short Term Debt51,436,000USD45,036,000USD38,612,000USD80,455,000USD65,796,000USD65,000,000USD208,000USD831,000USD
    Short Long Term Debt52,271,000USD45,036,000USD38,726,000USD80,455,000USD65,796,000USD65,000,000USD208,000USD831,000USD
    Short Long Term Debt Total62,266,000USD56,511,000USD50,665,000USD192,719,000USD182,898,000USD166,163,000USD144,594,000USD146,147,000USD
    Long Term Debt259,569,000USD228,374,000USD214,183,000USD101,956,000USD106,121,000USD89,824,000USD133,228,000USD133,124,000USD
    Net Receivables124,894,000USD92,458,000USD82,024,000USD101,035,000USD134,759,000USD125,213,000USD125,820,000USD155,424,000USD
    Accounts Payable11,672,000USD369,335,000USD9,929,000USD56,266,000USD68,218,000USD64,007,000USD54,637,000USD30,840,000USD
    Property Plant Equipment Net2,964,000USD3,374,000USD3,902,000USD4,687,000USD5,308,000USD5,734,000USD6,315,000USD7,537,000USD
    Common Stock Shares Outstanding8,417,000shares7,200,000shares3,268,000shares3,267,000shares3,260,000shares3,252,680shares3,294,000shares2,821,660shares
    Non Current Assets Total501,947,000USD523,558,000USD547,933,000USD575,054,000USD592,435,000USD599,280,000USD618,260,000USD650,655,000USD
    Non Current Liabilities Total281,839,000USD251,619,000USD240,682,000USD139,409,000USD155,757,000USD137,476,000USD164,104,000USD175,678,000USD
    Non Current Liabilities Other9,308,000USD9,308,000USD6,918,000USD22,157,000USD31,665,000USD26,001,000USD—4,907,000USD
    Non Currrent Assets Other25,994,000USD27,761,000USD31,119,000USD36,967,000USD33,238,000USD19,196,000USD17,080,000USD18,445,000USD
    Net Working Capital-353,275,000USD-412,174,000USD-288,323,000USD-348,467,000USD-315,599,000USD-312,275,000USD-190,245,000USD-110,150,000USD
    Unclassified Current Liabilities-52,271,000USD-45,036,000USD-38,726,000USD-80,455,000USD-65,796,000USD-65,000,000USD——
    Unclassified Non Current Liabilities12,962,000USD13,937,000USD19,581,000USD15,296,000USD17,971,000USD21,651,000USD30,876,000USD37,647,000USD
    Unclassified Equity506,370,000USD495,909,000USD556,936,000USD588,494,000USD586,923,000USD579,057,000USD565,018,000USD564,832,000USD
    Property Plant Equipment Gross—11,670,000USD12,002,000USD12,395,000USD12,579,000USD12,582,000USD12,588,000USD13,371,000USD
    Common Stock—————36,000USD36,000USD36,000USD
    Accumulated Other Comprehensive Income———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets656,641,000USD783,420,000USD860,967,000USD876,740,000USD2,364,108,460USD106,435,206USD65,605,126USD—
    Intangible Assets492,423,000USD574,350,000USD666,733,000USD751,050,000USD835,838,605USD———
    Other Current Assets15,613,000USD20,111,000USD8,227,000USD2,643,000USD7,315,353USD8,980,742USD1,795,855USD—
    Total Liab796,876,000USD633,891,000USD427,305,000USD354,081,000USD299,939,734USD236,652,911USD121,537,560USD—
    Total Stockholder Equity-155,232,000USD75,936,000USD142,130,000USD5,854,000USD2,064,168,726USD-130,217,705USD-42,052,124USD—
    Other Current Liab128,486,000USD367,408,000USD288,009,000USD63,707,000USD177,418,087USD78,732,954USD49,255,143USD—
    Capital Stock0USD36,000USD32,000USD24,000USD23,813USD45,579,304USD42,194,500USD—
    Retained Earnings-651,141,000USD-503,193,000USD-367,344,000USD-309,545,000USD-39,418,124USD-130,665,179USD-85,167,716USD—
    Cash25,012,000USD38,816,000USD36,320,000USD18,457,000USD140,477,586USD36,261,104USD32,592,495USD—
    Cash And Short Term Investments25,012,000USD38,816,000USD36,320,000USD18,457,000USD140,477,586USD36,261,104USD32,592,495USD—
    Total Current Assets133,083,000USD184,140,000USD166,017,000USD100,692,000USD199,860,950USD90,880,587USD52,354,383USD—
    Total Current Liabilities545,257,000USD496,415,000USD299,372,000USD241,664,000USD198,773,432USD90,616,067USD54,574,909USD—
    Net Debt262,273,000USD127,347,000USD88,321,000USD89,080,000USD-50,556,041USD15,025,394USD-9,936,556USD—
    Short Term Debt47,436,000USD65,000,000USD2,700,000USD1,600,000USD3,624,662USD2,264,083USD3,249,910USD—
    Short Long Term Debt45,036,000USD65,000,000USD——3,624,662USD89,988USD1,629,310USD—
    Short Long Term Debt Total287,285,000USD166,163,000USD124,641,000USD107,537,000USD89,921,545USD51,286,498USD22,655,939USD—
    Long Term Debt228,374,000USD89,824,000USD108,319,000USD94,421,000USD80,000,000USD45,387,986USD15,000,000USD—
    Net Receivables92,458,000USD125,213,000USD121,470,000USD79,592,000USD52,068,011USD45,638,741USD17,966,033USD—
    Accounts Payable369,335,000USD64,007,000USD8,663,000USD176,357,000USD17,730,683USD9,619,030USD2,069,856USD—
    Property Plant Equipment Net3,374,000USD5,734,000USD23,986,000USD20,539,000USD15,067,974USD10,878,829USD8,814,479USD—
    Property Plant Equipment Gross11,670,000USD12,582,000USD13,467,000USD8,839,000USD15,250,295USD12,471,656USD9,612,134USD—
    Common Stock Shares Outstanding3,269,000shares2,940,000shares1,898,000shares831,580shares41,578,890shares790,625shares475,880shares475,880shares
    Non Current Assets Total523,558,000USD599,280,000USD694,950,000USD776,048,000USD2,164,247,510USD15,554,619USD13,250,743USD—
    Non Current Liabilities Total251,619,000USD137,476,000USD127,933,000USD112,417,000USD101,166,302USD146,036,844USD66,962,651USD—
    Non Current Liabilities Other9,308,000USD26,001,000USD4,907,000USD4,794,000USD3,486,593USD———
    Non Currrent Assets Other27,761,000USD19,196,000USD4,231,000USD790,000USD3,590,715USD3,804,662USD3,695,136USD—
    Net Working Capital-412,174,000USD-312,275,000USD-133,355,000USD-140,972,000USD1,087,518USD-6,268,434USD-2,220,526USD—
    Unclassified Current Liabilities-45,036,000USD-65,000,000USD——-3,624,662USD—-30,345,089USD—
    Unclassified Non Current Liabilities13,937,000USD21,651,000USD14,707,000USD13,202,000USD2,810,290USD49,039,958USD4,406,029USD—
    Unclassified Equity495,909,000USD579,057,000USD509,410,000USD315,351,000USD2,103,539,224USD-142,767,507USD-41,764,270USD—
    Common Stock—36,000USD32,000USD24,000USD23,813USD97,188,204USD41,764,270USD—
    Current Deferred Revenue——-2,700,000USD-1,600,000USD——28,715,779USD—
    Inventory——-3,613,000USD-57,559,041,647USD—3,641,843USD1USD—
    Accumulated Other Comprehensive Income——0USD0USD—447,473USD921,092USD—
    Good Will———1,309,750,000USD1,309,750,216USD871,128USD741,128USD—
    Other Assets———4,290,000USD3,590,715USD3,804,662USD3,695,136USD—
    Unclassified Non Current Assets———-1,310,371,000USD—-3,804,662USD-3,695,136USD—
    Other Liab————14,869,419USD51,608,900USD47,556,622USD—
    Net Tangible Assets————-1,872,037,380USD-86,954,737USD-44,337,648USD—
    Unclassified Current Assets—————-3,641,843USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-18,954,000USD-165,714,000USD-31,587,000USD-43,665,000USD-44,246,000USD-58,617,000USD-46,512,000USD-12,020,000USD
    Depreciation21,074,000USD20,995,000USD21,033,000USD21,083,000USD21,052,000USD21,153,000USD21,673,000USD21,693,000USD
    Stock Based Compensation1,051,000USD1,099,000USD-597,000USD1,463,000USD1,808,000USD721,000USD1,958,000USD1,624,000USD
    Other Non Cash Items30,551,000USD65,244,000USD-26,725,000USD-7,898,000USD-9,953,000USD-44,508,000USD-46,752,000USD-28,775,000USD
    Change To Account Receivables-38,117,000USD-13,071,000USD15,273,000USD35,887,000USD-8,084,000USD624,000USD29,604,000USD-11,681,000USD
    Change In Working Capital-61,667,000USD49,781,000USD21,867,000USD12,384,000USD-2,127,000USD25,824,000USD48,973,000USD7,236,000USD
    Total Cash From Operating Activities-27,467,000USD-25,727,000USD-15,412,000USD-16,633,000USD-33,466,000USD-57,238,000USD-22,618,000USD-10,242,000USD
    Capital Expenditures0USD-198,000USD-119,000USD0USD0USD0USD0USD0USD
    Free Cash Flow-27,467,000USD-25,529,000USD-15,531,000USD-16,633,000USD-33,466,000USD-57,238,000USD-22,618,000USD-10,242,000USD
    Total Cashflows From Investing Activities-43,000USD198,000USD-119,000USD50,000USD—-475,000USD15,000,000USD—
    Net Borrowings27,835,000USD12,886,000USD14,659,000USD14,659,000USD30,796,000USD33,747,000USD-623,000USD—
    Total Cash From Financing Activities27,805,000USD12,874,000USD14,666,000USD14,617,000USD30,657,000USD33,717,000USD-2,486,000USD56,139,000USD
    Change In Cash295,000USD-12,655,000USD-865,000USD-1,966,000USD-2,809,000USD-23,996,000USD-10,104,000USD45,897,000USD
    Begin Period Cash Flow25,807,000USD38,462,000USD39,327,000USD41,293,000USD44,102,000USD68,098,000USD78,202,000USD32,305,000USD
    End Period Cash Flow26,102,000USD25,807,000USD38,462,000USD39,327,000USD41,293,000USD44,102,000USD68,098,000USD78,202,000USD
    Other Cashflows From Investing Activities-43,000USD—-316,250,000USD50,000USD—-475,000USD15,000,000USD—
    Other Cashflows From Financing Activities27,805,000USD-1,137,000USD301,658,347USD-42,000USD-139,000USD24,000USD-24,000USD-452,000USD
    Unclassified Financing Cash Flow-27,835,000USD1,125,000USD-301,651,347USD———-1,839,000USD56,621,000USD
    Unclassified Operating Cash Flow—2,868,000USD———-1,811,000USD-1,958,000USD—
    Investments——-119,000USD50,000USD0USD-475,000USD15,000,000USD0USD
    Unclassified Investing Cash Flow——316,369,000USD———-15,000,000USD—
    Sale Purchase Of Stock———————-30,000USD
    Issuance Of Capital Stock———————42,201,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-319,036,000USD-310,378,000USD-186,426,000USD-270,127,000USD-156,481,138USD-31,411,542USD-41,971,558USD-49,774,013USD
    Depreciation84,163,000USD86,058,000USD86,675,000USD87,289,000USD8,724,000USD795,172USD399,177USD342,196USD
    Stock Based Compensation5,581,000USD5,752,000USD5,979,000USD19,404,000USD—447,475USD474,042USD447,050USD
    Other Non Cash Items53,281,000USD21,553,000USD-12,553,000USD22,000,000USD—-21,018,656USD-1,620,600USD15,407,000USD
    Change To Account Receivables26,380,000USD-3,759,000USD-41,995,000USD-27,179,000USD448,000USD-27,368,028USD424,137USD-1,383,198USD
    Change In Working Capital81,905,000USD87,977,000USD30,297,000USD34,819,000USD42,404,000USD26,591,737USD8,068,777USD4,341,528USD
    Total Cash From Operating Activities-91,238,000USD-110,128,000USD-76,028,000USD-126,019,000USD-66,471,000USD-24,595,814USD-28,286,510USD-29,236,240USD
    Capital Expenditures-79,000USD0USD-1,827,000USD-2,233,000USD-3,410,000USD-2,926,621USD-1,451,861USD-3,308,638USD
    Free Cash Flow-91,159,000USD-110,128,000USD-77,855,000USD-128,252,000USD—-27,522,435USD-29,738,371USD-32,544,878USD
    Total Cashflows From Investing Activities129,000USD14,525,000USD-1,827,000USD-7,733,000USD-56,065,000USD-3,166,148USD-3,856,723USD-4,598,912USD
    Net Borrowings73,000,000USD58,955,000USD14,101,000USD11,375,000USD28,534,000USD34,940,061USD16,629,310USD—
    Total Cash From Financing Activities72,814,000USD98,771,000USD100,332,000USD11,375,000USD223,467,000USD34,760,061USD63,619,577USD33,250,078USD
    Change In Cash-18,295,000USD3,168,000USD22,477,000USD-122,376,872USD100,931,000USD6,998,099USD31,476,344USD-585,074USD
    Begin Period Cash Flow44,102,000USD40,934,000USD18,457,000USD140,833,872USD39,902,947USD32,904,848USD1,428,504USD2,013,579USD
    End Period Cash Flow25,807,000USD44,102,000USD40,934,000USD18,457,000USD39,902,947USD39,902,947USD32,904,848USD1,428,505USD
    Other Cashflows From Investing Activities50,000USD14,525,000USD—213,947USD213,000USD-109,527USD-2,404,862USD-1,290,274USD
    Unclassified Operating Cash Flow2,868,000USD——-19,404,000USD38,882,138USD—6,363,652USD—
    Investments—14,525,000USD-1,989,000USD-7,733,000USD—-3,166,148USD-3,856,723USD-4,598,912USD
    Other Cashflows From Financing Activities—39,816,000USD-364,000USD198,661,546USD-375,000USD-3,166,148USD16,164,914USD-4,598,912USD
    Unclassified Investing Cash Flow—-14,525,000USD1,989,000USD2,019,053USD-52,868,000USD3,036,148USD3,856,723USD4,598,912USD
    Sale Purchase Of Stock——-16,000USD——-180,000USD——
    Issuance Of Capital Stock——87,244,000USD87,329,000USD—0USD62,041,554USD—
    Unclassified Financing Cash Flow——86,611,000USD-285,990,546USD195,308,000USD3,346,148USD-31,216,201USD37,848,990USD
    Change To Liabilities———0USD41,956,000USD8,102,669USD803,503USD—
    Dividends Paid—————-180,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductCapitated Revenue379,499,000USD0001832511-26-000022
    Q1 2026Quarterly · 2026-03-31ProductHealth Care Care Coordination Management Fees6,518,000USD0001832511-26-000022
    Q1 2026Quarterly · 2026-03-31ProductHealth Care Clinical Fees Insurance Revenue263,000USD0001832511-26-000022
    Q1 2026Quarterly · 2026-03-31ProductHealth Care Incentive Fees110,000USD0001832511-26-000022
    Q4 2025Quarterly · 2025-12-31ProductCapitated Revenue366,183,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductHealth Care Care Coordination Management Fees2,711,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductHealth Care Clinical Fees Insurance Revenue384,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductHealth Care Incentive Fees15,536,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductCapitated Revenue1,428,979,000USD0001832511-26-000011
    FY 2025Yearly · 2025-12-31ProductHealth Care Care Coordination Management Fees10,823,000USD0001832511-26-000011
    FY 2025Yearly · 2025-12-31ProductHealth Care Clinical Fees Insurance Revenue3,056,000USD0001832511-26-000011
    FY 2025Yearly · 2025-12-31ProductHealth Care Incentive Fees16,222,000USD0001832511-26-000011
    Q3 2025Quarterly · 2025-09-30ProductCapitated Revenue341,555,000USD0001832511-25-000025
    Q3 2025Quarterly · 2025-09-30ProductHealth Care Care Coordination Management Fees2,750,000USD0001832511-25-000025
    Q3 2025Quarterly · 2025-09-30ProductHealth Care Clinical Fees Insurance Revenue872,000USD0001832511-25-000025
    Q3 2025Quarterly · 2025-09-30ProductHealth Care Incentive Fees76,000USD0001832511-25-000025
    Q2 2025Quarterly · 2025-06-30ProductCapitated Revenue351,724,000USD0001832511-25-000013
    Q2 2025Quarterly · 2025-06-30ProductHealth Care Care Coordination Management Fees2,667,000USD0001832511-25-000013
    Q2 2025Quarterly · 2025-06-30ProductHealth Care Clinical Fees Insurance Revenue808,000USD0001832511-25-000013
    Q2 2025Quarterly · 2025-06-30ProductHealth Care Incentive Fees589,000USD0001832511-25-000013
    Q1 2025Quarterly · 2025-03-31ProductCapitated Revenue369,517,000USD0001832511-26-000022
    Q1 2025Quarterly · 2025-03-31ProductHealth Care Care Coordination Management Fees2,695,000USD0001832511-26-000022
    Q1 2025Quarterly · 2025-03-31ProductHealth Care Clinical Fees Insurance Revenue992,000USD0001832511-26-000022
    Q1 2025Quarterly · 2025-03-31ProductHealth Care Incentive Fees21,000USD0001832511-26-000022
    Q4 2024Quarterly · 2024-12-31ProductCapitated Revenue367,456,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductHealth Care Care Coordination Management Fees1,800,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductHealth Care Clinical Fees Insurance Revenue1,346,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductHealth Care Incentive Fees84,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductCapitated Revenue1,483,602,000USD0001832511-26-000011
    FY 2024Yearly · 2024-12-31ProductHealth Care Care Coordination Management Fees10,563,000USD0001832511-26-000011
    FY 2024Yearly · 2024-12-31ProductHealth Care Clinical Fees Insurance Revenue5,934,000USD0001832511-26-000011
    FY 2024Yearly · 2024-12-31ProductHealth Care Incentive Fees356,000USD0001832511-26-000011
    Q3 2024Quarterly · 2024-09-30ProductCapitated Revenue357,706,000USD0001832511-25-000025
    Q3 2024Quarterly · 2024-09-30ProductHealth Care Care Coordination Management Fees2,770,000USD0001832511-25-000025
    Q3 2024Quarterly · 2024-09-30ProductHealth Care Clinical Fees Insurance Revenue1,536,000USD0001832511-25-000025
    Q3 2024Quarterly · 2024-09-30ProductHealth Care Incentive Fees112,000USD0001832511-25-000025
    Q2 2024Quarterly · 2024-06-30ProductCapitated Revenue374,306,000USD0001832511-25-000013
    Q2 2024Quarterly · 2024-06-30ProductHealth Care Care Coordination Management Fees3,603,000USD0001832511-25-000013
    Q2 2024Quarterly · 2024-06-30ProductHealth Care Clinical Fees Insurance Revenue1,107,000USD0001832511-25-000013
    Q2 2024Quarterly · 2024-06-30ProductHealth Care Incentive Fees141,000USD0001832511-25-000013
    FY 2023Yearly · 2023-12-31ProductCapitated Revenue1,252,309,000USD0001628280-24-013625
    FY 2023Yearly · 2023-12-31ProductHealth Care Care Coordination Management Fees8,301,000USD0001628280-24-013625
    FY 2023Yearly · 2023-12-31ProductHealth Care Clinical Fees Insurance Revenue5,192,000USD0001628280-24-013625
    FY 2023Yearly · 2023-12-31ProductHealth Care Incentive Fees573,000USD0001628280-24-013625
    FY 2023Yearly · 2023-12-31ProductHealth Care Shared Risk Revenue0USD0001628280-24-013625
    FY 2022Yearly · 2022-12-31ProductCapitated Revenue1,034,800,000USD0001628280-24-013625
    FY 2022Yearly · 2022-12-31ProductHealth Care Care Coordination Management Fees7,924,000USD0001628280-24-013625
    FY 2022Yearly · 2022-12-31ProductHealth Care Clinical Fees Insurance Revenue6,158,000USD0001628280-24-013625
    FY 2022Yearly · 2022-12-31ProductHealth Care Incentive Fees238,000USD0001628280-24-013625
    FY 2022Yearly · 2022-12-31ProductHealth Care Shared Risk Revenue351,000USD0001628280-24-013625
    FY 2021Yearly · 2021-12-02ProductCapitated Revenue567,735,000USD0001104659-23-039643
    FY 2021Yearly · 2021-12-02ProductHealth Care Care Coordination Management Fees5,880,000USD0001104659-23-039643
    FY 2021Yearly · 2021-12-02ProductHealth Care Clinical Fees Insurance Revenue4,318,000USD0001104659-23-039643
    FY 2021Yearly · 2021-12-02ProductHealth Care Incentive Fees67,000USD0001104659-23-039643
    FY 2021Yearly · 2021-12-02ProductHealth Care Shared Risk Revenue602,000USD0001104659-23-039643
    FY 2020Yearly · 2020-12-31ProductCapitated Revenue480,739,577USD0001558370-22-015154
    FY 2020Yearly · 2020-12-31ProductHealth Care Care Coordination Management Fees5,614,539USD0001558370-22-015154
    FY 2020Yearly · 2020-12-31ProductHealth Care Clinical Fees Insurance Revenue3,364,504USD0001558370-22-015154
    FY 2020Yearly · 2020-12-31ProductHealth Care Incentive Fees233,439USD0001558370-22-015154
    FY 2020Yearly · 2020-12-31ProductHealth Care Shared Risk Revenue1,111,466USD0001558370-22-015154
    FY 2019Yearly · 2019-12-31ProductCapitated Revenue139,332,707USD0001558370-22-015154
    FY 2019Yearly · 2019-12-31ProductHealth Care Care Coordination Management Fees1,893,553USD0001558370-22-015154
    FY 2019Yearly · 2019-12-31ProductHealth Care Clinical Fees Insurance Revenue3,312,107USD0001558370-22-015154
    FY 2019Yearly · 2019-12-31ProductHealth Care Incentive Fees11,444USD0001558370-22-015154
    FY 2019Yearly · 2019-12-31ProductHealth Care Shared Risk Revenue932,301USD0001558370-22-015154
    FY 2019Yearly · 2019-12-31ProductOther412,720USD0001558370-22-015154

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.